Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pubpat & their funding....

Pubpat & their funding....

posted on Apr 12, 2007 08:55AM

I can't wait to see, regardless of the results  of USPTO's re-exam of '336, just what those Asian/China companies [that are receiving BIG VC $$ from Gen Atlantic Partners & Tex Pacific, et al who more than likely are behind the Pubpat USPTO re-exam] are going to be forced to pay for the '584 & '148 regardless of the '336 outcome....

Get ready to fork it over boys

Share
New Message
Please login to post a reply